Research > ETFs > ETF / ETP Commentary > 

Top Performing Leveraged/Inverse ETFs: 09/14/2025

Top Performing Leveraged/Inverse ETFs Last WeekThese were last week’s top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly. Always do your homework.1. IONX – Defiance Daily Target 2X Long IONQ ETF The Defiance Daily Target 2X Long IONQ ETF, which seeks daily leveraged investment results of two times the daily percentage change in the share price of IonQ Inc., topped the levered ETFs last week with ~70% weekly returns. Following a series of positive analyst reports, shares of quantum computing hardware maker IonQ climbed last week. 2. RIOX – Defiance Daily Target 2X Long RIOT ETF RIOX aims to provide 2x long daily price performance of Riot Platforms, Inc., focusing on cryptocurrencies and cryptocurrency mining computers, ranked second on the list with over 39% weekly gains. Riot’s stock, along with other bitcoin miners, rallied last week as Bitcoin’s price surpassed the $114,300 level. 3. OKLL – Defiance Daily Target 2x Long OKLO ETF OKLL seeks to deliver 2x leveraged exposure to the daily share price movement of Oklo Inc. Class A (NYSE: OKLO). Oklo shares surged to a record high, fueled by favorable news in the nuclear sector. The rally was driven by a US Department of Energy call to increase uranium production and a new US-UK agreement to accelerate nuclear plant development. 4. BABX – GraniteShares 2x Long BABA Daily ETF BABX, which provides 2x leveraged exposure to the daily price movement for shares of Alibaba Group Holding Limited stock, was one of the leveraged ETFs making the list with ~29% weekly gains. Alibaba’s stock gained last week after the e-commerce giant announced a $3.2 billion convertible bond offering, a move seen as a significant investment in its artificial intelligence strategy. 5. HIMZ – Defiance Daily Target 2X Long HIMS ETF HIMZ seeks to deliver 2x leveraged exposure to the daily share price movement of Hims & Hers Health Inc. Shares of Hims & Hers increased after the company announced its entry into the testosterone replacement therapy market by launching a new men’s health service focused on personalized treatment plans. 6. HOOX – Defiance Daily Target 2X Long HOOD ETF HOOX, which seeks to provide 2x leveraged exposure to the daily share price movement of Robinhood Markets, Inc. (NASDAQ: HOOD), was another contender on the leveraged ETFs’ list with ~26% gains. The company’s upcoming addition to the S&P 500 index on Sept. 22, replacing Caesars Entertainment, is expected to boost its stock price due to mandatory index rebalancing. 7. TSLL – Direxion Daily TSLA Bull 2X Shares TSLL, which provides 2x leveraged exposure to the daily price movement for shares of Tesla stock, featured on the list of top-performing levered ETFs with ~26% returns in the last week. Tesla’s stock surged last week, after the CEO bought $1 billion in shares, a move investors saw as a powerful vote of confidence in the company’s future. 8. SMCX – Defiance Daily Target 2X Long SMCI ETF SMCX seeks to deliver 2x leveraged exposure to the daily share price movement of Super Micro Computer, Inc., and was one of the contenders on top-performing levered ETFs’ list with over 22% increase in the last week. SMCI shares surged after partnering with Nokia on AI data center solutions, a strategic move that transforms it from a server vendor into a full-stack AI infrastructure provider. 9. PLT – Defiance Leveraged Long Income PLTR ETF PLT is an actively managed fund, aiming to provide 1.5x to 2x leveraged exposure to the daily price movement of Palantir Technologies (PLTR), which rose last week, driven by AI growth. 10. KORU – Direxion MSCI Daily South Korea Bull 3X Shares KORU provides 300% daily leveraged exposure to an index of large- and mid-cap South Korean companies, featured on the list of top performing leveraged ETFs last week with 21% returns. The Korean market is surging due to the government’s decision to maintain the current stock capital gains tax threshold for major shareholders, which has removed significant uncertainty for investors. This, combined with optimism in the semiconductor industry and expectations for eased regulations on new industries, has further boosted market confidence. For more news, information, and analysis, visit the Leveraged & Inverse Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.